ArticleClinical journal of gastroenterology2025
Hepatic angiosarcoma presenting with clinical features of decompensated cirrhosis.
Article in Clinical journal of gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHepatic angiosarcoma (HAS) is a rare, highly aggressive vascular malignancy. HAS presents with nonspecific clinical and imaging findings, often leading to a delayed or missed diagnosis. We describe a case of HAS in a 78-year-old woman with the chief complaints of progressive abdominal distension and anorexia. She had no history of drinking or hepatotoxic medications. Serologic testing excluded viral and autoimmune hepatitis. Contrast-enhanced computed tomography showed no discrete hepatic mass but revealed diffusely heterogeneous low-attenuation areas with patchy arterial enhancement, marked ascites, prominent collateral vessels, and architectural distortion, all of which suggestive of decompensated cirrhosis. Liver biopsy was not performed due to severe coagulopathy and thrombocytopenia. Despite comprehensive supportive care that included liver-protective agents, diuretics, albumin, and plasma transfusion, her hepatic function progressively declined, and she succumbed to liver failure approximately 180 days after presentation. Postmortem needle necropsy ultimately revealed HAS.
conclusionHAS should be considered in the differential diagnosis of rapidly progressive hepatic failure of unknown etiology, especially when imaging results show diffuse hepatic involvement without a clear mass.
Indexed as
Identifiers
40658174What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.